Aprea Therapeutics, Inc. APRE Q4 2024 Annual earnings
Reported March 25, 2025 · Before market open
Revenue$205.8KMiss by $19.2K
EPS-$0.49Beat by $0.20
Revenue estimate$225.0K
EPS estimate-$0.69
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$253.0K
EPS estimate-$0.23
Versus estimates
Revenue
Q1 2026$281.0KQ4 2025$3.3KIn lineQ3 2025$1.8KQ2 2025$118.1KQ1 2025$162.5K
Q4 2024$205.8KMiss by $19.2K
Diluted EPS
Ask the moment Aprea Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aprea Therapeutics, Inc. report Q4 2024 earnings?
- Aprea Therapeutics, Inc. (APRE) reported Q4 2024 earnings on March 25, 2025 before market open.
- What were Aprea Therapeutics, Inc.'s Q4 2024 revenue and EPS?
- Aprea Therapeutics, Inc. reported revenue of $205.8K and eps of $-0.49 for Q4 2024.
- Did Aprea Therapeutics, Inc. beat estimates in Q4 2024?
- Revenue missed the consensus estimate of $225.0K by $19.2K. EPS beat the consensus estimate of $-0.69 by $0.20.
- Where can I find Aprea Therapeutics, Inc.'s Q4 2024 SEC filings?
- You can read the 10-K periodic report (0001558370-25-003588) directly on SEC EDGAR. The filing index links above go to sec.gov.